Joseph Jorizzo to Child, Preschool
This is a "connection" page, showing publications Joseph Jorizzo has written about Child, Preschool.
Connection Strength
0.346
-
Rattanakaemakorn P, Jorizzo JL. The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype). J Dermatolog Treat. 2018 Mar; 29(2):197-199.
Score: 0.117
-
Anderson K, Ascanio NM, Kinney MA, Krowchuk DP, Jorizzo JL. A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor. J Dermatolog Treat. 2016; 27(1):64-6.
Score: 0.102
-
Hundley JL, Carroll CL, Lang W, Snively B, Yosipovitch G, Feldman SR, Jorizzo JL. Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol. 2006 Feb; 54(2):217-20.
Score: 0.052
-
Sugai DY, Gustafson CJ, De Luca JF, Davis SA, Jorizzo JL, O'Rourke KS, Feldman SR. Trends in the outpatient medication management of lupus erythematosus in the United States. J Drugs Dermatol. 2014 May; 13(5):545-52.
Score: 0.023
-
Koch SB, Cerci FB, Jorizzo JL, Krowchuk DP. Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients. J Dermatolog Treat. 2013 Dec; 24(6):435-8.
Score: 0.022
-
Smith ES, Hallman JR, DeLuca AM, Goldenberg G, Jorizzo JL, Sangueza OP. Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol. 2009 Feb; 31(1):61-7.
Score: 0.016
-
Parish LC, Jorizzo JL, Breton JJ, Hirman JW, Scangarella NE, Shawar RM, White SM. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial. J Am Acad Dermatol. 2006 Dec; 55(6):1003-13.
Score: 0.014